Eggy burps on Saxenda are an unpleasant digestive symptom occasionally reported by patients taking this GLP-1 receptor agonist for weight management. Characterised by belching with a distinctive sulphurous or rotten egg odour, these burps result from hydrogen sulphide gas produced during bacterial breakdown of sulphur-containing proteins in the gut. Whilst not officially listed in Saxenda's product information, the medication's effect of slowing gastric emptying may contribute to altered digestive processes that produce this symptom. Understanding why eggy burps occur, how common they are, and practical management strategies can help patients navigate this side effect whilst continuing their weight management treatment under medical supervision.

Understanding Eggy Burps (Sulphur Burps) on Saxenda

Eggy burps, medically termed sulphur burps or eructation with hydrogen sulphide, are characterised by belching that produces a distinctive rotten egg odour. This unpleasant symptom occurs when hydrogen sulphide gas is released from the digestive system, typically as a result of bacterial breakdown of sulphur-containing proteins in the gastrointestinal tract. While eggy burps can occur in various digestive conditions, they have been anecdotally reported by some patients taking Saxenda (liraglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for weight management.

Saxenda is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with weight-related comorbidities such as type 2 diabetes or hypertension, as specified in the MHRA/EMC Summary of Product Characteristics. The medication works by mimicking the naturally occurring hormone GLP-1, which regulates appetite and food intake. However, its mechanism of action on the digestive system can lead to various gastrointestinal side effects, including nausea, constipation, diarrhoea, and in some cases, digestive symptoms that may include eggy burps.

Key characteristics of eggy burps include:

• A strong sulphurous or rotten egg smell when belching

• Often accompanied by bloating or abdominal discomfort

• May occur alongside other digestive symptoms such as nausea

• Can be intermittent or persistent depending on individual factors

It's important to note that eggy burps are not specifically listed as a side effect in the official Saxenda product information approved by the MHRA. However, patient reports suggest that some individuals do experience this symptom during treatment. Understanding the relationship between Saxenda and digestive symptoms can help patients manage expectations and seek appropriate support when needed.

Why Saxenda Causes Eggy Burps and Digestive Symptoms

The mechanism by which Saxenda may contribute to eggy burps likely relates to its pharmacological action on the gastrointestinal system. As a GLP-1 receptor agonist, liraglutide slows gastric emptying—the rate at which food moves from the stomach into the small intestine. This delayed gastric emptying is part of how the medication promotes satiety and reduces appetite, but it also means that food remains in the stomach for longer periods than usual.

When gastric emptying is delayed, food—particularly protein-rich foods containing sulphur-containing amino acids such as methionine and cysteine—undergoes prolonged exposure to gastric acid and digestive enzymes. This extended digestion time can alter the bacterial fermentation process in the gut. Certain bacteria in the gastrointestinal tract produce hydrogen sulphide gas as a byproduct when breaking down sulphur-containing compounds. When this gas accumulates and is expelled through belching, it produces the characteristic eggy or sulphurous odour.

Additional factors that may contribute to eggy burps on Saxenda include:

• Slowed gut motility: Increased intestinal transit time (slower movement through the gut) can affect bacterial populations and fermentation patterns

• Dietary composition: High-protein diets, commonly adopted during weight loss, contain more sulphur-containing amino acids

• Individual gut microbiome: Variations in intestinal bacteria affect how sulphur compounds are metabolised

• Dose escalation: As noted in the SmPC, gastrointestinal side effects are often dose-related and most common during dose escalation

It is important to note that there is no official direct link established between Saxenda and eggy burps in clinical trial data. However, the medication's known effects on gastrointestinal motility provide a plausible biological explanation for why some patients might experience this symptom. The interplay between delayed gastric emptying, dietary factors, and individual gut microbiome composition likely determines whether a patient develops eggy burps during treatment.

How Common Are Eggy Burps with Saxenda Treatment

Determining the precise prevalence of eggy burps among Saxenda users is challenging, as this specific symptom is not routinely captured in clinical trials or listed as a distinct adverse effect in regulatory documentation. According to the MHRA/EMC Summary of Product Characteristics, gastrointestinal disorders are very common (affecting more than 1 in 10 people), with nausea being the most frequently reported side effect, occurring in approximately 39% of patients in clinical trials. Other common gastrointestinal effects include diarrhoea (21%), constipation (20%), vomiting (16%), and dyspepsia (9%).

Eggy burps, when they occur, would likely fall under the broader categories of dyspepsia (indigestion) or eructation (belching), though these terms do not capture the specific sulphurous quality. Anecdotal reports from patient forums suggest that whilst not universal, eggy burps do affect a subset of Saxenda users, particularly during the initial weeks of treatment or following dose escalation.

Factors that may influence individual susceptibility include:

• Treatment duration: Symptoms often emerge during the titration phase when the body is adjusting to the medication

• Dose level: The maintenance dose of Saxenda is 3.0 mg once daily, and gastrointestinal effects may be more pronounced at this dose compared to lower titration doses

• Dietary habits: Patients consuming high-protein, low-carbohydrate diets may be more prone to sulphur-related symptoms

• Pre-existing digestive conditions: Those with irritable bowel syndrome or other gastrointestinal disorders may experience more symptoms

Most gastrointestinal side effects of Saxenda, including potential eggy burps, tend to improve over time as the body adapts to the medication. Clinical trial data indicates that nausea and other digestive symptoms typically diminish after the first few weeks of treatment, though individual experiences vary considerably.

Managing and Reducing Eggy Burps While Taking Saxenda

For patients experiencing eggy burps whilst taking Saxenda, several practical strategies may help reduce the frequency and severity of this symptom. These approaches focus on dietary modifications, eating habits, and lifestyle adjustments that can minimise sulphur production and gas accumulation in the digestive system.

Dietary modifications:

• Reduce sulphur-rich foods: Temporarily limit intake of eggs, red meat, poultry, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), garlic, onions, and dairy products

• Increase fibre gradually: Soluble fibre can support healthy digestion, but introduce it slowly to avoid exacerbating bloating

• Stay hydrated: Adequate water intake (approximately 2 litres daily) supports digestive function and may help reduce gas production

• Limit carbonated beverages: These can increase belching and may worsen symptoms

Eating habits and meal timing:

• Eat smaller, more frequent meals rather than large portions, which can overwhelm the already-slowed digestive system

• Chew food thoroughly and eat slowly to reduce air swallowing (aerophagia)

• Avoid lying down immediately after eating; remain upright for at least 2–3 hours post-meal

• According to the SmPC, Saxenda can be taken at any time, independent of meals. Some patients find a consistent injection time helps manage symptoms, but this is based on individual experience rather than clinical guidance

Additional supportive measures:

• Probiotics: Whilst evidence is limited, some patients report improvement with probiotic supplements that may help balance gut bacteria

• Peppermint tea: May provide symptomatic relief for bloating and digestive discomfort, though be aware it can worsen reflux in some people

• Physical activity: Gentle walking after meals can promote gastric emptying and reduce gas accumulation

• Over-the-counter remedies: Discuss with your pharmacist whether simethicone products might help reduce gas symptoms

Patients should maintain the prescribed Saxenda dose escalation schedule unless advised otherwise by their prescriber. Rapid dose increases may worsen gastrointestinal symptoms, so adhering to the gradual titration protocol (typically increasing by 0.6 mg weekly) allows the digestive system time to adapt. If symptoms are particularly troublesome, discuss with your GP or prescribing clinician whether temporarily maintaining a lower dose might be appropriate before continuing escalation to the maintenance dose of 3.0 mg once daily.

When to Seek Medical Advice About Saxenda Side Effects

Whilst eggy burps alone are generally not a cause for serious concern, certain accompanying symptoms warrant prompt medical evaluation. Patients should understand when digestive symptoms represent normal medication adjustment versus signs of potentially serious complications that require clinical assessment.

Contact your GP or prescribing clinician if you experience:

• Persistent or severe nausea and vomiting: Particularly if unable to keep down fluids, as this may lead to dehydration

• Severe abdominal pain: Especially if constant, radiating to the back, or accompanied by fever, which could indicate pancreatitis—a rare but serious side effect of GLP-1 receptor agonists

• Signs of gallbladder problems: Right upper abdominal pain, particularly after eating fatty meals, with or without jaundice (yellowing of skin or eyes)

• Persistent diarrhoea or constipation: Lasting more than a few days or significantly impacting quality of life

• Blood in vomit or stools: This requires urgent medical assessment

• Symptoms of dehydration: Excessive thirst, dark urine, dizziness, or reduced urination

• Hypoglycaemia symptoms: If you have diabetes and take insulin or sulfonylureas alongside Saxenda, watch for signs of low blood sugar (sweating, dizziness, confusion, hunger); dose adjustments of these medications may be needed

Seek immediate medical attention (call 999 or attend A&E) if you develop:

• Severe, persistent abdominal pain that does not resolve

• Signs of an allergic reaction: difficulty breathing, swelling of face or throat, severe rash

• Symptoms of acute pancreatitis: severe upper abdominal pain radiating to the back, nausea, vomiting, fever

For urgent but non-emergency concerns, contact NHS 111 for advice.

For eggy burps that persist beyond the first few weeks of treatment despite dietary modifications, or if they significantly impact your quality of life, schedule a routine appointment with your GP. Your clinician can assess whether the symptoms are related to Saxenda, review your overall tolerance of the medication, and consider whether continuing treatment remains appropriate. According to NICE guidance (TA664) and the Saxenda SmPC, treatment should only be continued if it produces at least 5% weight loss after 12 weeks at the maintenance dose of 3.0 mg daily.

If you experience side effects, consider reporting them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app). This helps authorities monitor medication safety.

If you need to stop Saxenda due to side effects, speak to a healthcare professional where possible, especially if you have type 2 diabetes, as this may affect your blood glucose control. Your healthcare provider can help you weigh the benefits of continued treatment against troublesome side effects and explore alternative weight management strategies if needed.

Frequently Asked Questions